Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Amortizatization of Intangibles (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Amortizatization of Intangibles for 10 consecutive years, with $215000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 67.96% to $215000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $778000.0, a 68.08% decrease, with the full-year FY2025 number at $778000.0, down 68.08% from a year prior.
  • Amortizatization of Intangibles was $215000.0 for Q4 2025 at Cartesian Therapeutics, up from $192000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q4 2023 to a low of -$763000.0 in Q3 2023.
  • A 5-year average of $323150.0 and a median of $231000.0 in 2022 define the central range for Amortizatization of Intangibles.
  • Biggest YoY gain for Amortizatization of Intangibles was 42500.0% in 2023; the steepest drop was 696.09% in 2023.
  • Cartesian Therapeutics' Amortizatization of Intangibles stood at $1.2 million in 2021, then crashed by 78.63% to $247000.0 in 2022, then surged by 578.14% to $1.7 million in 2023, then tumbled by 59.94% to $671000.0 in 2024, then plummeted by 67.96% to $215000.0 in 2025.
  • Per Business Quant, the three most recent readings for RNAC's Amortizatization of Intangibles are $215000.0 (Q4 2025), $192000.0 (Q3 2025), and $187000.0 (Q2 2025).